HMGB1 and Stroke: Our analyses unveiled a distinct linear trend, wherein the risk of developing post-stroke cognitive impairment escalated in lockstep with higher baseline circulating HMGB1 levels across the defined quartile strata among acute ischemic stroke patients (p < 0.001).